TRACEY JONES: Open Payments
NPI 1134171887 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 119 payments from 30 companies in 2025. Trend: 2023 $1,809 · 2024 $2,455 · 2025 $2,416
Food & beverage: $2,416
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $316 |
| Merck Sharp & Dohme LLC | 14 | $291 |
| Incyte Corporation | 11 | $228 |
| Janssen Biotech, Inc. | 12 | $200 |
| AstraZeneca Pharmaceuticals LP | 10 | $183 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| Daiichi Sankyo Inc. | 5 | $123 |
| E.R. Squibb & Sons, L.L.C. | 5 | $99 |
| Lilly USA, LLC | 5 | $97 |
| PFIZER INC. | 4 | $84 |
Products named: KEYTRUDA, LIBTAYO, MONJUVI, Fabhalta, IMFINZI, OPDIVO, VERZENIO, JAKAFI.
Industry payments across AL — which companies pay providers there.
